Immunome Inc. - IMNM
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Redmile Group, LLC | 5.2% | 5,718,385 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Jeremy C. Green | 5.2% | 5,718,385 | View |
| Dec 22, 2025 | SCHEDULE 13D/A | — | — | — | View |
| Nov 07, 2025 | SCHEDULE 13G | T. Rowe Price Investment Management, Inc. | 12.2% | 10,644,674 | View |
| Oct 07, 2025 | SCHEDULE 13G/A | FMR LLC | 15.0% | 13,056,709 | View |
| Oct 07, 2025 | SCHEDULE 13G/A | Abigail P. Johnson | 15.0% | 13,056,709 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.